Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cardiovascular Effects of Oligomeric Procyanidins (OPCs) in Smokers (INC001)

This study has been completed.
Information provided by (Responsible Party):
Antje Weseler, Maastricht University Medical Center Identifier:
First received: August 26, 2008
Last updated: October 28, 2011
Last verified: October 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2009
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):